Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

1
Exclusive: OxyContin maker Purdue taps financial restructuring adviser - sources

2018-08-17 channelnewsasia - 1
OxyContin maker Purdue Pharma LP has tapped law firm Davis Polk & Wardwell LLP for financial restructuring advice, as its potential liabilities swell with a wave of lawsuits over the opioid addiction epidemic sweeping the United States, people familiar with the matter said on Thursday.
ENL ENDP

0
Exclusive: OxyContin maker Purdue taps financial restructuring adviser - sources

2018-08-17 reuters
NEW YORK/BOSTON (Reuters) - OxyContin maker Purdue Pharma LP has tapped law firm Davis Polk & Wardwell LLP for financial restructuring advice, as its potential liabilities swell with a wave of lawsuits over the opioid addiction epidemic sweeping the United States, people familiar with the matter said on Thursday.
ENL ENDP

0
Trump administration proposes production quota cuts for six opioids

2018-08-16 channelnewsasia
WASHINGTON/NEW YORK: The Trump administration on Thursday proposed that U.S. drugmakers cut production quotas of the six most abused opioids by 10 percent next year to fight a nationwide addiction crisis.
ENL ENDP

0
UPDATE 2-Trump administration proposes production quota cuts for six opioids

2018-08-16 reuters
WASHINGTON/NEW YORK (Reuters) - The Trump administration on Thursday proposed that U.S. drugmakers cut production quotas of the six most abused opioids by 10 percent next year to fight a nationwide addiction crisis.
ENL ENDP

1
Amneal Pharmaceuticals (AMRX) Jumps: Stock Rises 5.6%

2018-08-14 zacks - 1
Amneal Pharmaceuticals, Inc. (AMRX - Free Report) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 14.2% in the past one-month time frame.
ENL ENDP

0
10 Stocks Receiving Multiple Analyst Upgrades and Price Target Hikes

2018-08-09 247wallst
Earnings season is going strong, and many brokerage firm analysts are raising targets and ratings on their favorite stocks. The Thursday morning list of full analyst upgrades and downgrades included about 20 companies, but there were many companies which received multiple analyst upgrades or price target hikes after strong news.
EQIX KORS ENL CUB GDOT AYX ENDP

0
Endo (ENDP) Beats on Q2 Earnings & Sales, Raises Guidance

2018-08-09 zacks
Shares of Endo International plc (ENDP - Free Report) gained 28.3% after the company reported better-than-expected second-quarter 2018 results. The company increased its outlook for the year.
SGEN VRTX GD ZTO ENL ENDP

0
Endo International Plc (ENDP) Q2 2018 Results - Earnings Call Transcript

2018-08-08 seekingalpha
Good day, ladies and gentlemen, and welcome to the Endo International Second Quarter 2018 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. As a reminder, this conference call may be recorded.
DB ENL ENDP

3
Implied Volatility Surging for Endo International (ENDP) Stock Options

2018-08-08 zacks
Investors in Endo International plc (ENDP - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Aug 10, 2018 $11.00 Put had some of the highest implied volatility of all equity options today.
VREX ELY IPGP RYB ENL ENDP

2
Endo International (ENDP) Tops Q2 Earnings and Revenue Estimates

2018-08-08 zacks
Endo International (ENDP - Free Report) came out with quarterly earnings of $0.76 per share, beating the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.93 per share a year ago. These figures are adjusted for non-recurring items.
NRCI NRC ELY SLDA NRCIA OBSV NRCIB ENL ENDP

0
Endo International plc 2018 Q2 - Results - Earnings Call Slides

2018-08-08 seekingalpha
The following slide deck was published by Endo International plc in conjunction with their 2018 Q2 earnings call.
ENL ENDP

0
Is a Beat in Store for Horizon Pharma (HZNP) in Q2 Earnings?

2018-08-06 zacks
Horizon Pharma plc (HZNP - Free Report) is scheduled to report second-quarter 2018 results on Aug 8, before the opening bell.
MDGL ENL HZNP BGSF BPL ENDP

10
Your Daily Pharma Scoop: Insmed's AdCom, Opko Progresses, Roche PRIMEd

2018-08-06 seekingalpha - 2
Insmed up 7% premarket ahead of Ad Com review of inhalable amikacin for NTM lung disease
ACOR ABC OPK HIK INSM ENL SLXP ENDP

5
Allergan Sues Pfizer Over Opioid Drug

2018-08-03 biospace
Dublin-based Allergan is suing New York-based Pfizer over a morphine-based opioid, Kadian, that Allergan acquired in December 2008. The drug was originally owned by King Pharmaceuticals, which was subsequently acquired by Pfizer in 2010.
AGN CAH ENL ACT ENDP

13
UPDATE 1-U.S. subpoenas AmerisourceBergen over opioid products

2018-08-02 reuters
Aug 2 (Reuters) - Drug wholesale distributor AmerisourceBergen Corp said on Thursday it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to opioid products and its communications with a drugmaker.
ABC MCK CAH ENL ENDP

Related Articles

RNVA: Rennova Health Analysis and Research Report

2018-08-18 - Asif

Business overview Rennova Health, Inc. (together with its subsidiaries, “Rennova”, “we” or the “Company”) is a provider of an expanding group of health care services for healthcare providers, patients and individuals. Beginning in 2018, the Company intends to focus on and operate two synergistic divisions: 1) Clinical diagnostics through its clinical laboratories; and 2) Hospital operations through its Big South Fork Medical Center, which opened on August 8, 2017, and a hospital in Jamestown Tennessee, including a doctor’s practice, the assets of which the company expect to acquire in the second quarter of 2018, pursuant to the terms of a definitive asset purchase agreement that the company entered into on January 31, 2018, as more fully discussed below. The company believe that its approach will produce a more sustainable business model and the capture of multiple revenue streams from medical providers, patients and hospital services. Management determined that because Big So...

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...